Therapeutic Asset Ratings
474 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Olvimulogene Nanivacirepvec
High-grade Serous Ovarian Cancer
Genelux Corporation
P3
B
(60)
Olvimulogene Nanivacirepvec
Ovarian Clear Cell Carcinoma
Genelux Corporation
P3
B
(60)
Olvimulogene Nanivacirepvec
Platinum-refractory Ovarian Cancer
Genelux Corporation
P3
B
(60)
Rgx-121
MPS II
REGENXBIO Inc.
P3
B
(60)
Oncos-102
Advanced or Unresectable Melanoma Progressing After PD1 Blockade
Targovax Oy
P2
B
(60)
Bbm-H901
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China
P2/3
B
(60)
gc101
Adverse Drug Event
Shanghai Juncell Therapeutics
P1/2
B
(60)
Pelareorep
Recurrent Plasma Cell Myeloma
University of Southern California
P1/2
B
(60)
DIRLOCTOCOGENE SAMOPARVOVEC
Hemophilia A
Spark Therapeutics, Inc.
P3
B
(59)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE
Merkel Cell Carcinoma
University of Zurich
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Fallopian Tube Mucinous Adenocarcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Fallopian Tube Serous Adenocarcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Fallopian Tube Transitional Cell Carcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Fallopian Tube Undifferentiated Carcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Ovarian Clear Cell Adenocarcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Ovarian Mucinous Adenocarcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Ovarian Seromucinous Carcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Ovarian Serous Adenocarcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Ovarian Transitional Cell Carcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Ovarian Undifferentiated Carcinoma
Mayo Clinic
P2
B
(59)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Platinum-Resistant Ovarian Carcinoma
Mayo Clinic
P2
B
(59)
DNA (synthetic adeno-associated virus 9 vector scAAV9.U1a.hSGSH human N-Sulfoglucosamine sulfohydrolase-specifying)
MPS IIIA
Ultragenyx Pharmaceutical Inc
P2/3
B
(59)
DNA (synthetic adeno-associated virus 9 vector scAAV9.U1a.hSGSH human N-Sulfoglucosamine sulfohydrolase-specifying)
Sanfilippo Syndrome
Ultragenyx Pharmaceutical Inc
P2/3
B
(59)
gc101
Tumor Infiltrating Lymphocytes
Shanghai Juncell Therapeutics
P1/2
B
(59)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE
Cutaneous Melanoma
University of Louisville
P3
B
(58)
Showing 26 to 50 of 474 assets
Previous
Page 2 of 19
Next
